In a precedent-setting decision, the United States Department of Agriculture (USDA) has granted permission to two American firms, Upside Foods and GOOD Meat, to market lab-grown chicken in the country. This move marks a significant development in the synthetic meat industry, particularly for poultry products.
The review and approval process involved both the USDA’s Food Safety and Inspection Service (FSIS) and the Food and Drug Administration (FDA), exhibiting an interagency collaboration that ensures the safety and integrity of this novel food. The comprehensive cooperation between these two agencies is an assurance of the thoroughness of the assessment process, giving credibility to the safety of these lab-grown products.
Upside Foods, previously known as Memphis Meats, has been at the forefront of cellular agriculture, crafting meat directly from animal cells without the need to raise and slaughter animals. GOOD Meat, a subsidiary of Eat Just, utilizes a similar approach. The approval of their products underscores the viability of the paradigm shift towards sustainable and ethical meat production.
However, it’s crucial to note that this approval does not automatically translate to global acceptance. Different countries and regions have their own regulatory landscapes and cultural differences that may affect the adaption of lab-grown meat. Some consumers may still be reticent about consuming meat produced in a lab, emphasizing the need for education and awareness campaigns.
The decision of the USDA and the FDA will undoubtedly spur more interest and investment in cellular agriculture. As an essential development, it may catalyze a chain reaction of many similar authorizations in other parts of the world, thus propelling the entire industry forward.
For additional detail on the approvals and what they mean for the cellular agriculture industry, read Morgan Lewis ‘s article on JD Supra.